MAPT and Parkinson disease: A note of caution is advised in the interpretation of PD and DLB results, however, given that the affinity of the existing tau tracers for the hallmark pathology observed in these disorders, α-synuclein, is not fully understood (for a detailed description, please refer to the section “Tracer specificity for tau”).